Sign up now and fund within 24h to get A$10.
Claim It Now
Stake logo
LoginOpen an accountSign up
​

AGN

Trade Now
Compare

Argenica Therapeutics Limited

1 day chart

Created with Highcharts 11.1.0
Get A$10 trading credit to start you off

Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.

Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.

T&Cs apply
Claim now
Get A$10 trading credit to start you off

About AGN

Argenica Therapeutics Limited (AGN) is into research and development of a neuroprotective therapeutic drug. The Company is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Find out what a historical investment in Argenica Therapeutics Limited would be worth today using our AGN stock calculator.

Sector

Health Care

CEO

-

Industry

Pharmaceuticals

Website

argenica.com.au

Market Capitalisation

$92M

Price-earnings ratio

-13.58

Dividend yield

-

High today

$0.75

Low today

$0.72

Open price

$0.75

52-week high

$0.99

52-week low

$0.60

Ready to start your investing journey with Stake?

Open an account

Announcements

AGN FAQs

Buying AGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Argenica Therapeutics Limited in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in AGN
The ticker symbol for Argenica Therapeutics Limited is AGN.
One share of AGN is valued at $0.72 as of 15 May 2025.
As of 15 May 2025 Argenica Therapeutics Limited has a market cap of $92M.
The Price to Earnings ratio of AGN is -13.58.
The Earnings Per Share of AGN is -$0.05.
The Argenica Therapeutics Limited 52-week high stock price is $0.99.
The Argenica Therapeutics Limited 52-week low stock price is $0.60.
Yes, the Stake investing platform allows you to buy AGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in AGN
on Stake

Buy AGN from A$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started
Stake app chart
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
AGN related stocks
CAN logo

Cann Group Limited

CAN

+6.25%

BOT logo

Botanix Pharmaceuticals Ltd

BOT

-5.00%

AVE logo

Avecho Biotechnology Limited

AVE

+0.00%

AGH logo

Althea Group Holdings Limited

AGH

+0.00%

ECS logo

ECS Botanics Holdings Ltd

ECS

-16.67%

Stake logo
Over 12,000 5-star reviews
App Store logoGoogle Play logo

Investing

Product

Account

Learn

Company

Legal

Contact Us

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.
Region: au
Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The Stake Accumulate Fund (ARSN 680 653 374) is issued by K2 Asset Management Ltd (ABN 95 085 445 094 AFSL 244 393), a wholly owned subsidiary of K2 Asset Management Holdings Ltd (ABN 59 124 636 782). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services Guide, Terms & Conditions, Privacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2025 Stake. All rights reserved.

This site uses cookies. By using our site you agree to the Stake Privacy Policy.